查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2030 年微针给药系统市场预测：按组件、类型、材料、应用、最终用户和地区进行的全球分析
市场调查报告书
商品编码
1383477

2030 年微针给药系统市场预测：按组件、类型、材料、应用、最终用户和地区进行的全球分析

Microneedle Drug Delivery Systems Market Forecasts to 2030 - Global Analysis By Component, Type, Material, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球微针给药系统市场规模为 58.9 亿美元，预计在预测期内年复合成长率为 9.4%，到 2030 年将达到 110.4 亿美元。

用于药物、疫苗和其他治疗剂的规范且有效的经皮给药的装置被称为微针药物递送系统市场。微针是一种微创针，其目的是在皮肤最外层创建微通道，允许皮内或经皮给药药物和生物活性物质。该针将用于无痛疫苗接种，提高疫苗接种率并使免疫接种对患者更加友善。

根据 ACS 发表的一篇论文，2020 年 5 月，匹兹堡大学医学中心和匹兹堡大学的研究人员尝试开发微针阵列（MNA）。它是一个指尖大小的贴片，带有 400 个微型针头，可将尖刺蛋白质片段注入免疫反应最强的皮肤中。

加强公共卫生倡议

微针具有改变疫苗接种等公共卫生活动的巨大潜力，因为它们可以进行无痛和微创的药物输送。透过提供比传统注射更舒适和熟悉的选择，该小工具改善了疫苗接种的机会并减少了焦虑。透过减少与针头相关的不适，微针可以提高疫苗的可接受性和依从性，最终提高免疫普及。因此，改善健康和疾病控制的目标与微针给药系统在公共卫生计画中的部署是一致的，这是这项尖端医疗技术发展的驱动力。

製造昂贵的微针

製造这些专用设备需要复杂的工程技术、精确的品管以及生物相容性材料的使用。这些因素增加了生产成本，限制了市场潜力。然而，这种成本可能会导致使用微针的产品价格更高。这些费用可能使患者和提供者难以获得治疗并限制治疗的采用。

改善药物吸收和生物利用度

微针在皮肤中形成的微通道使药物输送更有效。药物可以透过微针绕过消化器官系统，这可能会缩短作用时间并提高生物利用度。这可能会导致作用持续时间缩短并提高生物利用度。这可以让更有效的治疗以更低的剂量更有效地给药，减少副作用的可能性，并有可能改善患者的治疗结果。此外，提高药物吸收和生物利用度的能力代表了药物传输领域的重大进步，使微针成为製药公司、医疗专业人员和寻求增强治疗选择的患者的一个引人注目的主张。

药物相容性有限

儘管微针是一种有前途且用户友好的药物给药方法，但并非所有药物都适合该技术。微针的组成和设计可以限制可使用的药物具有某些品质，例如适当的分子大小、溶解度和稳定性。这种限制限制了可以透过微针有效输送的药物和生技药品的类型，并可能阻止一些基本药物从这种新型输送系统中受益。然而，为某些药物製造基于微针的设备可能需要一些时间和费用。

COVID-19 的影响：

政府的封锁措施以及医院和诊所的关闭导致因生活方式选择而导致慢性病患者的护理中断。随着 COVID-19 感染频率的增加，该公司和学术机构正致力于开髮用于大流行药物给药的指尖大小的皮肤贴片。因此，采用微针进行 COVID-19 疫苗接种影响了大流行期间的市场成长。

涂层微针技术领域预计将在预测期内成为最大

预计在预测期内，涂层微针技术领域将占据最大份额。这项最尖端科技允许在微针表面涂覆生物相容性涂层，以适应多种应用。这些涂层可以提高敏感化学物质的稳定性，控制药物和治疗剂的释放，并提高微针产品的保质期。此外，患者体验和疗效的改善正在推动微针给药系统产业的成长。

预计皮肤科在预测期内年复合成长率最高

皮肤科领域预计将呈现良好的成长动能。微针技术透过给药精确、微创的药物、皮肤护理产品和美容治疗方式，正在彻底改变皮肤病治疗。此外，以微针为基础的皮肤科手术也称为微针治疗，可以治疗多种皮肤问题，包括皱纹、痤疮疤痕、色素沉着和老化症状。

占比最大的地区：

在预测期内，由于感染疾病、皮肤病和慢性病的盛行率不断上升，给药系统技术进步的成长以及製造业中先进技术和系统的采用不断增加，北美将占据最大的市场份额微针。预计会占据。此外，法规程序包括严格的评估、临床测试和遵守品质标准，以确保患者安全和产品功效。北美微针给药系统的开发和普及将继续受到支持新的患者友善给药技术的政府倡议和法规以及公共卫生优先事项的影响。

复合年复合成长率最高的地区：

由于製药业的扩张和对先进药物输送技术的需求不断增长，预计亚太地区在预测期内将实现盈利增长。这些倡议的核心是改善微针的成分和结构，改善药物输送系统，并扩大其在疫苗接种、皮肤病学和慢性病护理等领域的使用范围。此外，政府机构和学术机构之间的合作也推动了该地区的技术创新。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球微针给药系统市场：依组成部分

  • 涂层微针技术
  • 中空微针技术
  • 固体微针技术
  • 其他组件

第6章全球微针给药系统市场：依类型

  • 溶解微针技术
  • 多孔微针
  • 3D列印微针
  • 水凝胶微针
  • 其他类型

第7章全球微针给药系统市场：依材料分类

  • 生物分解性微针材料
  • 陶瓷
  • 金属
  • 金属合金
  • 聚合物
  • 硅
  • 其他材料

第8章全球微针给药系统市场：依应用分类

  • 癌症治疗
  • 皮肤科
  • 荷尔蒙的输送
  • 胰岛素给药
  • 肿瘤学
  • 疼痛管理
  • 儿童医学
  • 经皮经皮
  • 疫苗递送
  • 其他用途

第9章全球微针给药系统市场：依最终用户分类

  • 药局
  • 医院
  • 医疗服务提供方
  • 其他最终用户

第10章全球微针给药系统市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东/非洲

第11章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第12章公司简介

  • 3M
  • 3D-Micromac AG
  • Becton, Dickinson and Company
  • Candela Corporation
  • Clearside Biomedical, Inc.
  • Corium Inc.
  • Dermaroller GmbH
  • Dynatrace
  • Genex Technologies
  • Georgia Institute of Technology
  • Innoture Medical Technology Limited
  • LTS Lohmann Therapie-Systeme AG
  • Micron Biomedical Inc.
  • Micropoint Technologies
  • My Life Technologies
  • NanoSmart Pharmaceuticals, Inc.
  • Nitto Denko Corporation
  • PreCelleon Medical Inc.
  • Rani Therapeutics
  • Raphas Co. Ltd
  • TheraJect Inc.
  • Transdermal Technologies, Inc.
  • Valeritas, Inc.
  • Vaxess Technologies
  • Zosano Pharma
  • Zydis
Product Code: SMRC24325

According to Stratistics MRC, the Global Microneedle Drug Delivery Systems Market is accounted for $5.89 billion in 2023 and is expected to reach $11.04 billion by 2030 growing at a CAGR of 9.4% during the forecast period. The devices for the regulated and effective transdermal delivery of medications, vaccines, and other therapeutic agents is known as the microneedle drug delivery systems market. The goal of microneedles, which are minimally invasive needles, is to make microchannels in the skin's outermost layer so that drugs and bioactive substances can be administered intra- or transdermally. They are used to provide painless vaccination, increasing vaccine coverage and making immunization more patient-friendly.

According to an article published by ACS, in May 2020, the researchers at the University of Pittsburgh Medical Center and the University of Pittsburgh tried to develop a microneedle array (MNA), a fingertip-sized patch with 400 microscopic needles that inject spiked protein fragments into the skin, where an immune response is most potent.

Market Dynamics:

Driver:

Enhancement of public health initiatives

With their painless and minimally intrusive drug delivery capabilities, microneedles hold enormous potential for transforming public health initiatives such as immunization campaigns. By providing a more comfortable and approachable option to traditional injections, these gadgets increase accessibility to immunization and reduce anxiety. Microneedles can promote increased vaccine acceptance and compliance by lessening the discomfort associated with needle injections, which will ultimately result in higher immunization coverage rates. Therefore, the goal of improving health outcomes and disease control is aligned with the deployment of microneedle drug delivery systems in public health programs, which is a driving force behind the development of this cutting-edge medical technology.

Restraint:

Expensive production of microneedles

These specialized gadgets need complex engineering, precise quality control, and the use of biocompatible materials in their creation and manufacturing. These elements limit the market potential by raising the cost of production. However, this cost can lead to increased prices for products that use microneedles. These expenses may restrict the adoption of the treatment by making it difficult for patients and healthcare providers to obtain care.

Opportunity:

Increasing drug absorption and bioavailability

Drug delivery is made more effective by the microchannels that are created in the skin by microneedles. Drugs can avoid the gastrointestinal system due to microneedles, which may result in a shorter duration of action and better bioavailability. This may lead to lower doses of more potent treatments that are more effective, lowering the possibility of adverse effects and enhancing patient outcomes. Furthermore, the capacity to augment drug absorption and bioavailability signifies a significant advancement in the domain of drug delivery, rendering microneedles a compelling choice for pharmaceutical corporations, healthcare professionals, and patients in search of enhanced therapeutic alternatives.

Threat:

Limited drug compatibility

Even though microneedles present a promising and user-friendly method of drug administration, not all drugs are appropriate for use with this technology. Microneedles' composition and design may limit the medications that can be used with them to those that have certain qualities, including the right molecular size, solubility, and stability. This constraint limits the types of drugs and biologics that may be delivered with microneedles in an efficient manner, which may prevent some essential drugs from benefiting from this novel delivery system. However, it can take some time and be expensive to build microneedle-based devices for particular medications.

COVID-19 Impact:

The government's lockdown methods and the hospital and clinic closures resulted in a disruption of care for people with chronic illnesses brought on by their lifestyle choices. Because of the increasing frequency of COVID-19 infections, businesses and academic institutions are concentrating more on developing fingertip-sized skin patches for pandemic medication administration. Thus, the adoption of microneedles for COVID-19 immunization affected the market's growth during the pandemic.

The coated microneedle technology segment is expected to be the largest during the forecast period

Coated microneedle technology segment is expected to hold largest share during the forecast period. With this cutting-edge technology, the surface of microneedles with biocompatible coatings can be coated for a variety of uses. These coatings can be made to improve the stability of sensitive chemicals, control the release of medications or therapeutic agents, or improve the shelf life of microneedle products. Additionally, due to the improved patient experience and efficacy, which is fueling the growth of the microneedle drug delivery systems industry.

The dermatology segment is expected to have the highest CAGR during the forecast period

Dermatology segment is estimated to witness lucrative growth. Microneedle technology is transforming dermatological treatments by providing a precise and minimally invasive way to administer drugs, skincare products, and cosmetic therapies. Furthermore, microneedle-based dermatological operations, also known as microneedling, can treat a variety of skin issues, including wrinkles, acne scars, pigmentation, and aging symptoms.

Region with largest share:

Over the course of the forecast period, North America is anticipated to hold the largest share of the market due to an increase in the prevalence of infectious, skin, and chronic diseases; a growth in the technological advancement of drug delivery systems; an increase in the adoption of highly advanced techniques and systems in the fabrication of microneedles. Additionally, to guarantee patient safety and product efficacy, the regulatory procedure involves stringent evaluations, clinical trials, and adherence to quality standards. The development and uptake of microneedle drug delivery systems in North America will continue to be influenced by government initiatives and regulations that support new and patient-friendly drug delivery technologies as well as the prioritization of public health.

Region with highest CAGR:

The Asia Pacific region is anticipated to have profitable growth during the forecast period as a result of the expanding pharmaceutical sector and the growing need for advanced drug delivery techniques. These initiatives center on improving the composition and structure of microneedles, refining drug delivery systems, and broadening the scope of uses in areas such as vaccination, dermatology, and chronic illness care. Moreover, innovation in the region is also being promoted by partnerships among government agencies and academic institutions.

Key players in the market

Some of the key players in Microneedle Drug Delivery Systems market include: 3M, 3D-Micromac AG, Becton, Dickinson and Company, Candela Corporation, Clearside Biomedical, Inc., Corium Inc., Dermaroller GmbH, Dynatrace, Genex Technologies, Georgia Institute of Technology, Innoture Medical Technology Limited, LTS Lohmann Therapie-Systeme AG, Micron Biomedical Inc., Micropoint Technologies, My Life Technologies, NanoSmart Pharmaceuticals, Inc., Nitto Denko Corporation, PreCelleon Medical Inc., Rani Therapeutics, Raphas Co. Ltd, TheraJect Inc., Transdermal Technologies, Inc., Valeritas, Inc., Vaxess Technologies, Zosano Pharma and Zydis.

Key Developments:

In August 2023, Mind Medicine, a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced that it has entered into a license agreement with Catalent, a leader in enabling the development and supply of better treatments for patients worldwide, to access Catalent's proprietary Zydis® orally disintegrating tablet (ODT) technology.

In December 2022, Emergex looks to microneedle patches with Zosano Pharma acquisition. The assets acquired include intellectual property, license agreements, and manufacturing equipment. They also include Zosano's proprietary microneedle array patch (MAP) intradermal drug delivery system, including a reusable applicator, solid coated microneedle array patch technology, product packaging, methods for formulation and microneedle coating, and specialized equipment, designed and built for clinical and commercial manufacture of the technology.

In November 2022, CGBio, a South Korean healthcare provider, launched a skin trouble care patch, CGDew Derma Regen, in its microneedle pipeline. These microneedle patches are made from a range of materials, such as silicon, titanium, stainless steel, and polymers, to improve the diffusivity of medications to the stratum corneum by forming pores on the skin that are smaller than a micron.

In October 2022, Emergex Vaccines Holding Limited acquired the assets of Zosano Pharma Corporation. The assets include intellectual property, license agreements, manufacturing equipment, Zosano's proprietary microneedle array patch (MAP) intradermal drug delivery system, solid-coated microneedle array patch technology, methods for formulation and microneedle coating, and specialized equipment.

Components Covered:

  • Coated Microneedle Technology
  • Hollow Microneedle Technology
  • Solid Microneedle Technology
  • Other Components

Types Covered:

  • Dissolving Microneedle Technology
  • Porous Microneedles
  • 3D-Printed Microneedles
  • Hydrogel Microneedles
  • Other Types

Materials Covered:

  • Biodegradable Microneedle Materials
  • Ceramics
  • Metal
  • Metal Alloys
  • Polymer
  • Silicon
  • Other Materials

Applications Covered:

  • Cancer Therapy
  • Dermatology
  • Hormone Delivery
  • Insulin Delivery
  • Oncology
  • Pain Management
  • Pediatric Medicine
  • Transdermal Drug Delivery
  • Vaccine Delivery
  • Other Applications

End Users Covered:

  • Pharmacies
  • Hospitals
  • Healthcare Providers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Microneedle Drug Delivery Systems Market, By Component

  • 5.1 Introduction
  • 5.2 Coated Microneedle Technology
  • 5.3 Hollow Microneedle Technology
  • 5.4 Solid Microneedle Technology
  • 5.5 Other Components

6 Global Microneedle Drug Delivery Systems Market, By Type

  • 6.1 Introduction
  • 6.2 Dissolving Microneedle Technology
  • 6.3 Porous Microneedles
  • 6.4 3D-Printed Microneedles
  • 6.5 Hydrogel Microneedles
  • 6.6 Other Types

7 Global Microneedle Drug Delivery Systems Market, By Material

  • 7.1 Introduction
  • 7.2 Biodegradable Microneedle Materials
  • 7.3 Ceramics
  • 7.4 Metal
  • 7.5 Metal Alloys
  • 7.6 Polymer
  • 7.7 Silicon
  • 7.8 Other Materials

8 Global Microneedle Drug Delivery Systems Market, By Application

  • 8.1 Introduction
  • 8.2 Cancer Therapy
  • 8.3 Dermatology
  • 8.4 Hormone Delivery
  • 8.5 Insulin Delivery
  • 8.6 Oncology
  • 8.7 Pain Management
  • 8.8 Pediatric Medicine
  • 8.9 Transdermal Drug Delivery
  • 8.10 Vaccine Delivery
  • 8.11 Other Applications

9 Global Microneedle Drug Delivery Systems Market, By End User

  • 9.1 Introduction
  • 9.2 Pharmacies
  • 9.3 Hospitals
  • 9.4 Healthcare Providers
  • 9.5 Other End Users

10 Global Microneedle Drug Delivery Systems Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 3M
  • 12.2 3D-Micromac AG
  • 12.3 Becton, Dickinson and Company
  • 12.4 Candela Corporation
  • 12.5 Clearside Biomedical, Inc.
  • 12.6 Corium Inc.
  • 12.7 Dermaroller GmbH
  • 12.8 Dynatrace
  • 12.9 Genex Technologies
  • 12.10 Georgia Institute of Technology
  • 12.11 Innoture Medical Technology Limited
  • 12.12 LTS Lohmann Therapie-Systeme AG
  • 12.13 Micron Biomedical Inc.
  • 12.14 Micropoint Technologies
  • 12.15 My Life Technologies
  • 12.16 NanoSmart Pharmaceuticals, Inc.
  • 12.17 Nitto Denko Corporation
  • 12.18 PreCelleon Medical Inc.
  • 12.19 Rani Therapeutics
  • 12.20 Raphas Co. Ltd
  • 12.21 TheraJect Inc.
  • 12.22 Transdermal Technologies, Inc.
  • 12.23 Valeritas, Inc.
  • 12.24 Vaxess Technologies
  • 12.25 Zosano Pharma
  • 12.26 Zydis

List of Tables

  • Table 1 Global Microneedle Drug Delivery Systems Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Microneedle Drug Delivery Systems Market Outlook, By Component (2021-2030) ($MN)
  • Table 3 Global Microneedle Drug Delivery Systems Market Outlook, By Coated Microneedle Technology (2021-2030) ($MN)
  • Table 4 Global Microneedle Drug Delivery Systems Market Outlook, By Hollow Microneedle Technology (2021-2030) ($MN)
  • Table 5 Global Microneedle Drug Delivery Systems Market Outlook, By Solid Microneedle Technology (2021-2030) ($MN)
  • Table 6 Global Microneedle Drug Delivery Systems Market Outlook, By Other Components (2021-2030) ($MN)
  • Table 7 Global Microneedle Drug Delivery Systems Market Outlook, By Type (2021-2030) ($MN)
  • Table 8 Global Microneedle Drug Delivery Systems Market Outlook, By Dissolving Microneedle Technology (2021-2030) ($MN)
  • Table 9 Global Microneedle Drug Delivery Systems Market Outlook, By Porous Microneedles (2021-2030) ($MN)
  • Table 10 Global Microneedle Drug Delivery Systems Market Outlook, By 3D-Printed Microneedles (2021-2030) ($MN)
  • Table 11 Global Microneedle Drug Delivery Systems Market Outlook, By Hydrogel Microneedles (2021-2030) ($MN)
  • Table 12 Global Microneedle Drug Delivery Systems Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 13 Global Microneedle Drug Delivery Systems Market Outlook, By Material (2021-2030) ($MN)
  • Table 14 Global Microneedle Drug Delivery Systems Market Outlook, By Biodegradable Microneedle Materials (2021-2030) ($MN)
  • Table 15 Global Microneedle Drug Delivery Systems Market Outlook, By Ceramics (2021-2030) ($MN)
  • Table 16 Global Microneedle Drug Delivery Systems Market Outlook, By Metal (2021-2030) ($MN)
  • Table 17 Global Microneedle Drug Delivery Systems Market Outlook, By Metal Alloys (2021-2030) ($MN)
  • Table 18 Global Microneedle Drug Delivery Systems Market Outlook, By Polymer (2021-2030) ($MN)
  • Table 19 Global Microneedle Drug Delivery Systems Market Outlook, By Silicon (2021-2030) ($MN)
  • Table 20 Global Microneedle Drug Delivery Systems Market Outlook, By Other Materials (2021-2030) ($MN)
  • Table 21 Global Microneedle Drug Delivery Systems Market Outlook, By Application (2021-2030) ($MN)
  • Table 22 Global Microneedle Drug Delivery Systems Market Outlook, By Cancer Therapy (2021-2030) ($MN)
  • Table 23 Global Microneedle Drug Delivery Systems Market Outlook, By Dermatology (2021-2030) ($MN)
  • Table 24 Global Microneedle Drug Delivery Systems Market Outlook, By Hormone Delivery (2021-2030) ($MN)
  • Table 25 Global Microneedle Drug Delivery Systems Market Outlook, By Insulin Delivery (2021-2030) ($MN)
  • Table 26 Global Microneedle Drug Delivery Systems Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 27 Global Microneedle Drug Delivery Systems Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 28 Global Microneedle Drug Delivery Systems Market Outlook, By Pediatric Medicine (2021-2030) ($MN)
  • Table 29 Global Microneedle Drug Delivery Systems Market Outlook, By Transdermal Drug Delivery (2021-2030) ($MN)
  • Table 30 Global Microneedle Drug Delivery Systems Market Outlook, By Vaccine Delivery (2021-2030) ($MN)
  • Table 31 Global Microneedle Drug Delivery Systems Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 32 Global Microneedle Drug Delivery Systems Market Outlook, By End User (2021-2030) ($MN)
  • Table 33 Global Microneedle Drug Delivery Systems Market Outlook, By Pharmacies (2021-2030) ($MN)
  • Table 34 Global Microneedle Drug Delivery Systems Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 35 Global Microneedle Drug Delivery Systems Market Outlook, By Healthcare Providers (2021-2030) ($MN)
  • Table 36 Global Microneedle Drug Delivery Systems Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.